Supplement companies recover from an FTC action or a safety recall the same way: accept court-enforced restructuring instead of fighting it, keep operating under real oversight, and let outside buyers or regulators validate the fix over time. Herbalife, Hydroxycut, and Airborne all show that pattern, across a pyramid-scheme finding, a liver-injury recall, and a false-advertising case. One case here shows what happens without it.
How Did Herbalife Recover From Its 2016 FTC Pyramid Scheme Settlement?
Herbalife recovered by accepting a complete restructuring of how it pays distributors, rather than continuing to fight the underlying business-model question in court. After a multi-year FTC investigation and a public four-year campaign by hedge fund manager Bill Ackman, who took a $1 billion short position betting the company would collapse, Herbalife agreed in July 2016 to pay $200 million in consumer redress and restructure its U.S. compensation plan.Under the consent order, at least two-thirds of distributor rewards must now come from verified retail sales rather than recruitment, and an independent compliance auditor monitors the company's adherence for seven years. FTC Chairwoman Edith Ramirez said the settlement would "require Herbalife to fundamentally restructure its business so that participants are rewarded for what they sell, not how many people they recruit." Ackman predicted the restructuring would cause the company to collapse; instead, Herbalife continued operating as a public company under the new model, with Wall Street responding positively to the settlement news itself.
How Has Hydroxycut Survived Two Separate FDA Recalls?
Hydroxycut's history is a genuinely mixed recovery, not a clean one, and that honesty is the useful lesson. The supplement was first reformulated after the FDA banned its original stimulant, ephedra, in 2004, then recalled a second time in May 2009 after the FDA identified 23 adverse event reports of liver damage, including one death and two liver transplants, tied to the reformulated version.Manufacturer Iovate Health Sciences voluntarily recalled all 14 affected products and had a reformulated version, containing only one ingredient from the prior formula, back on store shelves within about a month, appearing at retailers like Vitamin Shoppe by June 2009. The brand still sells today under repeated later reformulations. But critics have pointed out this is also a caution: a class-action suit was still allowed to proceed years later, and consumer advocates have publicly questioned how a product recalled twice for serious health risks continues operating with largely similar marketing claims each time. Hydroxycut's case shows that a fast recall and reformulation can keep a brand on shelves, without necessarily resolving the underlying question of why the same problem recurred.
How Did Airborne Recover From Its False Advertising Settlements?
Airborne's recovery shows that a supplement brand can rebuild enough trust to be acquired at a premium, even after regulators and researchers publicly debunked its central marketing claim. Airborne marketed its effervescent tablets as clinically proven to prevent and treat colds, a claim based on a study later revealed by ABC News to have been conducted by a two-person operation with no actual doctors or scientists involved.The company settled a private class action for $23.3 million in 2008, then reached a separate FTC settlement bringing total available consumer redress to $30 million, and a further $7 million multistate settlement with attorneys general in 2009, in each case agreeing to stop making unsubstantiated cold-prevention claims. Airborne continued operating and was acquired by Schiff Nutrition for $150 million in March 2012, and Schiff itself was acquired by Reckitt Benckiser for $1.4 billion eight months later, a chain of transactions that would not have happened at those valuations if buyers saw the settlements as a sign the brand was permanently damaged.
What Happens When a Supplement Company Doesn't Recover From a Safety Crisis?
Not every supplement crisis ends in a comeback, and USPlabs' OxyElite Pro shows what the alternative costs. After a 2013 outbreak of acute hepatitis and liver failure in Hawaii, linked to an unapproved ingredient called aegeline, was tied to dozens of hospitalizations, two liver transplants, and one death, USPlabs recalled the product and destroyed its remaining inventory.Rather than settle quickly, USPlabs and its contract manufacturer fought federal criminal charges for years after a 2015 grand jury indictment. In 2019, the company's CEO and president both pleaded guilty to conspiracy to introduce misbranded food into interstate commerce, alongside three other defendants, with the group facing a combined $60 million in fines and prison time. Unlike Herbalife's restructuring or Airborne's acquisitions, there was no later buyer or continued public operation to point to: the criminal case effectively ended USPlabs as a going concern.
What Do These Supplement Industry Recoveries Have in Common?
Across Herbalife, Hydroxycut, and Airborne, the same three elements show up regardless of whether the crisis was a business-model finding, a safety recall, or a marketing claim:- Accepting a court-enforced structural change rather than contesting the underlying finding. Herbalife's compensation overhaul and Airborne's advertising restrictions both took effect quickly once the companies stopped fighting and started complying.
- Independent verification built into the settlement itself. Herbalife's seven-year independent compliance auditor is a stronger signal to regulators and the public than any company statement about improved practices.
- Continued operation that lets outside markets re-validate the brand over time. Airborne's sale to Schiff and Schiff's sale to Reckitt Benckiser are market-based confirmations that a supplement brand's post-settlement value can recover fully.
What Metrics Show a Supplement Brand's Reputation Recovery Is Working?
The three recovery cases above were tracked on different metrics, and supplement brand PR teams should expect to use a mix of the same ones rather than a single score:- Regulatory consent order compliance, verified by an independent monitor where one is required, which is a stronger signal than a company's own compliance claims
- Recall completion and reformulation speed, since Hydroxycut's roughly one-month turnaround from recall to a reformulated product back on shelves shows how quickly the market can re-accept a brand, for better or worse
- Acquisition or investment activity, since Airborne's sequential sales at rising valuations are a direct market signal that outside buyers saw the brand as recovered
- Criminal versus civil resolution, since a civil settlement like Herbalife's or Airborne's preserves a path to continued operation, while a criminal conviction, as in USPlabs' case, generally does not
How Should a Supplement Company Apply These Lessons to Its Own Crisis Plan?
A supplement brand preparing for its own FTC, FDA, or safety crisis should work through these steps before a crisis hits, not during one:- Decide in advance to negotiate a settlement with structural commitments rather than litigate a legitimate regulatory finding, since Herbalife's and Airborne's fastest paths back to normal operation both ran through settlement, not trial.
- Build a real, board-level food-safety or compliance function now, so a recall isn't the first time the company builds this capability.
- Verify every clinical or efficacy claim made in advertising before publishing it, since Airborne's core problem was a claim that could not survive outside scrutiny once a journalist looked into it.
- Prepare a clear, honest account of what changed structurally after a recall, since Hydroxycut's case shows that speed to relaunch without addressing why the same problem recurred leaves a company exposed to the next incident.
- Recognize that cooperating with civil regulators preserves options a criminal referral does not; USPlabs' path from safety incident to criminal indictment shows how much is at stake in that distinction.
